It is therefore likely that these drugs will succeed in counteracting the physiological adaptations normally caused by weight loss (increased appetite, in particular), but that these adaptations quickly take over after stopping the medication and promote the return to the initial overweight, before treatment
Theyre prized as a fix for everything from stubborn weight to constant cravings, with results that can feel fast
Expert Care Skilled professionals dedicated to your well-being Safe Procedure Committed to safety with every treatment
An MJFF-funded Phase IIb placebo-controlled trial did show mild benefit but because the placebo group also improved, the significance of these results is unclear
What to Expect During the Transition Discontinuing GLP-1 therapy is not associated with severe addiction-like withdrawal
HUM delivers 10 g of Fibersol-2, matching the dose that raised postprandial GLP-1 by roughly 40% in trial conditions